Innate Pharma S.A. (IPHA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.02
0.01 (0.50%)
At close: Oct 03, 2025, 3:58 PM
2.03
0.50%
After-hours: Oct 03, 2025, 04:00 PM EDT

Innate Pharma S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
12.62M 51.9M 57.67M 12.11M
Cost of Revenue
51.98M 56.02M 51.66M 47M
Gross Profit
12.62M 5.62M 6.01M -22.3M
Operating Income
-51.58M -12.67M -57.42M -47.83M
Interest Income
2.44M 3.18M 546K 327K
Pretax Income
-49.47M -7.57M -57.97M -45.48M
Net Income
-49.47M -7.57M -58.1M -52.81M
Selling & General & Admin
11.93M 11.75M 14.47M 25.52M
Research & Development
51.98M 56.02M 51.66M 47M
Other Expenses
283K -49.48M -2.7M -47M
Operating Expenses
64.2M 18.29M 63.44M 25.52M
Interest Expense
566K 640K 288K 312K
Selling & Marketing Expenses
n/a n/a 530K 9.53M
Cost & Expenses
64.2M 74.31M 115.1M 59.94M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
81.05M 84.11M 79.59M 79.54M
Shares Outstanding (Diluted)
81.05M 84.11M 79.64M 79.54M
EPS (Basic)
-0.61 -0.09 -0.73 -0.57
EPS (Diluted)
-0.61 -0.09 -0.73 -0.57
EBITDA
-46.91M -1.84M -12.28M -43.23M
EBIT
-48.91M -6.93M -57.68M -47.83M
Depreciation & Amortization
1.99M 5.09M 45.41M 4.6M